Precision Perioperative Treatment for Resectable Non-Small Cell Lung Cancer: Current Status and Perspectives
The treatment paradigm for resectable non-small cell lung cancer (NSCLC) continues to evolve toward precision perioperative strategies. Despite curative-intent surgery, disease recurrence remains common. Adjuvant tyrosine kinase inhibitors have substantially improved disease-free survival and, in selected populations,...